Drug Development Pipeline | Pharma Analysis

Pharmapremia gives you the ability to accurately benchmark internal and external R&D candidates’ chances of approval and potential development timelines. You can use these benchmarks to make informed decisions about drug pipeline prioritization, partnerships and acquisitions.

How it can help

Pharmapremia allows you to look at product success factors across the variables that matter to you and your business. Its robust dataset includes detailed information from the entire drug-development industry, from big pharma to private biotech, oncology to orphan diseases.

This data gives you an exclusive window into drug development pipelines and paints a fuller, clearer picture of how the industry is performing.

How it works

Effectively manage your portfolio risk by accessing comprehensive data sets including Probability of Overall Success (POS), Likelihood of Approval (LOA) and Phase and Overall Duration.

Pharmapremia covers over 8,000 programs including over 2,200 in oncology, over 1,100 in orphan diseases, and over 500 indications.

The data you need to make the right decisions

What's included

Below are the Feature List

Manage portfolio risks

Analyze success factors

Create meaningful benchmarks

Drug success rate methodology

Pharma Intelligence: latest

Oncology Success Rates Webinar Recording

Looking to benchmark internal and external R&D candidates’ chances of approval?

Meet the team

Below are the Analyst Profile

Ellen Moore

Management, Director - Pharma Consulting

Next steps

This is Contactus Section

Request a Demo

How can we help you?

Report store

Pharmapremia: Benchmark better and optimize your drug development pipeline